The current research & development by business enterprise, pharmaceutical industry in constant ppp $ in the Czech Republic is 91.31 million, which has increased by 0.83 million (0.9%) since 2021.
Research & development by business enterprise, pharmaceutical industry in constant PPP $ in the Czech Republic
No matching regions
Similar regions to the Czech Republic
Business R&D pharmaceutical in constant PPP $
More indicators for the Czech Republic
Czech Republic Business R&D pharmaceutical in constant PPP $ between 1996 and 2022
Period | Business R&D pharmaceutical in constant PPP $ | Change |
---|---|---|
2022 | 91.31M | +0.83M |
2021 | 90.48M | +1.16M |
2020 | 89.32M | +0.85M |
2019 | 88.47M | -12.86M |
2018 | 101.33M | +17.37M |
2017 | 83.96M | -3.00M |
2016 | 86.96M | +0.07M |
2015 | 86.89M | +3.02M |
2014 | 83.88M | +5.11M |
2013 | 78.76M | -11.83M |
2012 | 90.59M | +1.96M |
2011 | 88.64M | +1.88M |
2010 | 86.75M | -9.77M |
2009 | 96.53M | +6.24M |
2008 | 90.29M | -2.95M |
2007 | 93.23M | +12.66M |
2006 | 80.58M | +9.58M |
2005 | 70.99M | -6.54M |
2004 | 77.54M | +28.16M |
2003 | 49.37M | -5.34M |
2002 | 54.71M | +13.54M |
2001 | 41.17M | +3.08M |
2000 | 38.09M | +12.11M |
1999 | 25.98M | +4.82M |
1998 | 21.16M | +4.71M |
1997 | 16.45M | -8.67M |
1996 | 25.12M |